These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7955026)

  • 1. Sex-specific differences in mortality after high-titre measles immunization in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Markowitz L; Rhodes P; Whittle H
    Bull World Health Organ; 1994; 72(5):761-70. PubMed ID: 7955026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of vaccine efficacy and mortality during routine use of high-titre Edmonston-Zagreb and Schwarz standard measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Markowitz L; Whittle H
    Trans R Soc Trop Med Hyg; 1996; 90(3):326-30. PubMed ID: 8758096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa.
    Aaby P; Ibrahim SA; Libman MD; Jensen H
    Vaccine; 2006 Apr; 24(15):2764-71. PubMed ID: 16457909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Child mortality after high-titre measles vaccines: prospective study in Senegal.
    Garenne M; Leroy O; Beau JP; Sene I
    Lancet; 1991 Oct; 338(8772):903-7. PubMed ID: 1681265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five year follow-up of morbidity and mortality among recipients of high-titre measles vaccines in Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Markowitz L; Whittle H
    Vaccine; 1996 Feb; 14(3):226-9. PubMed ID: 8920704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of high-titre measles vaccines administered from the age of five months: a community study in rural Senegal.
    Samb B; Aaby P; Whittle H; Seck AM; Simondon F
    Trans R Soc Trop Med Hyg; 1993; 87(6):697-701. PubMed ID: 8296384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Whittle H
    Am J Epidemiol; 1993 Nov; 138(9):746-55. PubMed ID: 8237989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
    Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
    N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
    Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of three measles vaccines in Indian children.
    Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM
    Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
    Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
    Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines.
    Whittle H; Aaby P; Samb B; Cissé B; Kanteh F; Soumaré M; Jensen H; Bennett J; Simondon F
    Pediatr Infect Dis J; 1999 Jan; 18(1):53-7. PubMed ID: 9951981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies.
    Aaby P; Jensen H; Samb B; Cisse B; Sodemann M; Jakobsen M; Poulsen A; Rodrigues A; Lisse IM; Simondon F; Whittle H
    Lancet; 2003 Jun; 361(9376):2183-8. PubMed ID: 12842371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-specific changes in the female-male mortality ratio related to the pattern of vaccinations: an observational study from rural Gambia.
    Aaby P; Jensen H; Walraven G
    Vaccine; 2006 May; 24(22):4701-8. PubMed ID: 16621182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
    Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.
    Kiepiela P; Coovadia HM; Loening WE; Coward P; Botha G; Hugo J; Becker PJ
    Bull World Health Organ; 1991; 69(2):221-7. PubMed ID: 1860150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.